In this episode, Dr. Douglas Graham, Chief of the Aflac Cancer and Blood Disorders Center, shares progress in pediatric leukemia and sickle cell disease treatments, the impact of a 30-year partnership with Aflac, and breakthroughs in precision medicine, CAR T-cell therapy, and gene therapy that are reshaping outcomes for children and families.
Dr. Douglas Graham, Chief of the Aflac Cancer and Blood Disorders Center
Next Up in Becker’s Pediatric Leadership Podcast
-
In this episode, Jason Shenefield, MBA, FACHE, President and Chief Executive Officer of Phelps Health, discusses expanding affordable care through…
-
In this episode, Matthew Hurford, President and CEO of Community Care Behavioral Health at UPMC, discusses workforce development, the growth…
-
In this episode, Marlon F. Levy, MD, MBA, FACS, Chief Executive Officer of VCU Health System and Senior Vice President…
Comments are closed.